Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 1183-1188, February 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaczynski, M.
Right arrow Articles by Briggs, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaczynski, M.
Right arrow Articles by Briggs, R. C.

cis-Diamminedichloroplatinum(II) Cross-Linking of the Human Myeloid Cell Nuclear Differentiation Antigen to DNA in HL-60 Cells following 1,25-Dihydroxy Vitamin D3-induced Monocyte Differentiation1

Marek Gaczynski, Judith A. Briggs, Andrzej Wedrychowski, Ryszard Olinski, Milan Uskokovic, Jane B. Lian, Gary S. Stein and Robert C. Briggs2

Departments of Biochemistry [M. G., J. A. B., A. W., R. O., R. C. B.] and Pathology [R. C. B.] and Center in Molecular Toxicology [M. G., J. A. B., A. W., R. O., R. C. B.], Vanderbilt University School of Medicine, Nashville, Tennessee 37232; Hoffman-LaRoche Inc., Nutley, New Jersey 07110 [M. U.]; and Department of Cell Biology, University of Massachusetts Medical Center, Worcester, Massachusetts 01655 [J. B. L., G. S. S.]

Protein-DNA interactions of the human myeloid cell nuclear differentiation antigen (MNDA) were examined in vivo in proliferating HL-60 promyelocytic leukemia cells and following induction of differentiation by 1,25-dehydroxyvitamin D3. Intact cells were treated with the reversible cross-linking agent cis-diamminedichloroplatinum(II) and the MNDA levels in the isolated protein-DNA complexes were determined. Less than 1% of the toal intracellular level of MNDA was cross-linked to DNA in the noninduced proliferating HL-60 cells. Once the cells were induced to differentiate into monocytes, the amount of antigen cross-linked to the DNA increased to over 5% of the total intracellular level. The increased efficiency of cross-linking the MNDA to DNA was specific for monocyte-induced HL-60 differentiation, achieved with three inducers, and was not observed in association with granulocyte-induced differentiation. On a molar basis the phorbol ester (12-O-tetradecanoylphorbol-13-acetate) was the most effective inducer of monocyte differentiation, followed by 1,25-dihydroxy-16-ene-23-ynecholecalciferol which was more effective than 1,25-dihydroxycholecalciferol. A cesium chloride gradient analysis of the nucleic acid-protein fraction isolation from cis-diamminedichloroplatinum(II)-treated, monocyte-induced HL-60 cells documented the authenticity of the association between the MNDA and DNA. The results indicate that a significant level of chromatin reorganization may accompany monocyte-induced differentiation that leads to much higher levels of MNDA-DNA cross-linking to DNA. The expression of the MNDA is restricted to human myeloid cells and the present results indicate that a fraction of this low abundance nuclear protein is specifically located near the DNA [within cis-diamminedichloroplatinum(II) cross-linking distance] and that this association may be modulated specifically during monocyte differentiation.

1 Supported by NIH Grants CA 37097 and ES 00267.

2 To whom requests for reprints should be addressed, at Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232.

Received 5/ 5/89. Revised 9/29/89. Accepted 11/ 8/89.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
P. A. Hershberger, T. F. McGuire, W.-D. Yu, E. G. Zuhowski, J. H. M. Schellens, M. J. Egorin, D. L. Trump, and C. S. Johnson
Cisplatin Potentiates 1,25-Dihydroxyvitamin D3-induced Apoptosis in Association with Increased Mitogen-activated Protein Kinase Kinase Kinase 1 (MEKK-1) Expression
Mol. Cancer Ther., August 1, 2002; 1(10): 821 - 829.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. A. Moffatt, W. U. Johannes, and G. J. Miller
1{{alpha}},25-Dihydroxyvitamin D3 and Platinum Drugs Act Synergistically to Inhibit the Growth of Prostate Cancer Cell Lines
Clin. Cancer Res., March 1, 1999; 5(3): 695 - 703.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.